Introduction
Zanthoxylum schinifolium (Rutaceae) is an aromatic plant, whose pericarp is widely used as a pungent condiment and seasoning in Korea and in other East Asian countries.1 The leaves, fruits, seeds and roots of Z. schinifolium have been used in the treatment of various diseases, such as inflammation, toothache, muscle pain, and ascarid.2-4 Medicinal activities have also been reported from this plant, including anti-platelet aggregation, anti-oxidant, inhibition of the production of monoamine oxidase, and anti-tumor.5-8 Despite many researches on Z. schinifolium, our aim is focused on the investigation into cytotoxic components from Z. schinifolium. Thus, the roots, stems, pericarps, and seeds of Z. schinifolium were extracted using MeOH, while the leaves were extracted using 80% MeOH. These extracts were examined for MTT cytotoxicity against the Jurkat T cell lines, and the result revealed that the leaves extract had a potent MTT cytotoxicity. The leaves extract was subsequently fractionated into four parts: methylene chloride, ethyl acetate, n-butanol, and water fractions. The methanol extract and fractions were examined for their cytotoxicity using an in vitro MTT assay on Jurkat T cells. Among the samples tested, the methylene chloride fraction showed the strongest inhibition against Jurkat T cell lines. Thus, assaydirected separation of this methylene chloride fraction has led to the isolation of nine active principles, including four coumarinoids (1 − 4), two triterpenoids (5, 6), and three fatty acid derivatives (7 − 9). In this study, the isolation, structural elucidation, along with the cytotoxicity of the isolates will be discussed herein.
Experimental
General experimental procedures – Melting points were determined on a Yanaco micro melting point apparatus. Optical rotations were measured on a JASCO DIP-370 digital polarimeter (Japan). IR spectra were measured on a Mattson Polaris FT/IR-300E spectrophotometer. UV spectra were measured on a Thermo 9423 AQA2200E UV spectrophotometer. The NMR spectra were recorded on a Varian Unity INOVA-400 spectrometer (USA), and chemical shifts are expressed as δ value using TMS as an internal standard. Low- and highresolution EI-MS data were collected on a Quattro II spectrometer. Silica gel 60 (70 - 230 and 230 - 400 mesh, Merck) and Lichroprep RP-18 (40 - 63 μm, Merck) were used as stationary phases for column chromatography. For TLC and HPTLC, silica gel 60 F254 (EM 5715, 5628) glass plates (0.25mm) were used and visualized by spraying with 10% H2SO4 and subsequent heating. All other chemicals and solvents were of analytical grade and used without further purification.
Plant material − The leaves of Z. schinifolium were collected in Gyeongsan, Gyeongbuk, Republic of Korea in June 2004. These materials were confirmed taxonomically by Professor Chong Won Kim, Catholic University of Daegu, Gyeongsan, Republic of Korea. A voucher specimen has been deposited at the College of Pharmacy, Catholic University of Daegu.
Extraction and isolation − The leaves of Z. schinifolium (30 kg) were freeze-dried and powdered, to yield 10 kg of leaf powder. The powder was extracted with 80% MeOH, to yield 1.2 kg of extract, upon removal of the solvent. The MeOH extract was mixed in H2O (5 L), and the resulting H2O layer was partitioned with CH2Cl2 (4 L × 311 g), n-BuOH (4 L × 385 g) and H2O (300 g). The CH2Cl2 extract (311 g) was loaded on a silica gel column (9 × 75 cm, silica-gel 230~400 mesh), and eluted by a stepwise gradient of n-hexane-EtOAc (100 : 0 to 1 : 100). The eluates were combined into 23 pools (SL-MC-A~W), on the basis of silica gel TLC. SL-MC-K (3.0 g) was chromatographed on a reverse-phase column (3.5 × 15 cm, RP C-18, and eluted by a stepwise gradient of H2O-MeOH (40 : 60 to 0 : 100)), to yield compound 1 (500.1 mg). SL-MC-Q (89.3 mg) was chromatographed on a reverse-phase column (3.5 × 15 cm, RP C-18, and eluted by a stepwise gradient of H2O-MeOH (30 : 70 to 0 : 100), to yield compound 2 (4.2 mg). SL-MC-F (1.6 g) was chromatographed on a silica gel column (3.5 × 15 cm, using the n-hexane-CH2Cl2 mixture as a solvent, and eluted with a stepwise gradient (100 : 1 to 40 : 1)), to yield compound 6 (400.4 mg). SL-MC-H (2.0 g) was chromatographed on a silica gel column (3.5 × 15 cm, using the n-hexane-EtOAc mixture as a solvent, and eluted with a stepwise gradient (100 : 1 to 50 : 1)), to yield compounds 5 (100.2 mg) and 7 (550.1 mg), respectively. SL-MC-I (2.8 g) was chromatographed on a silica gel column (3.5 × 15 cm, using the n-hexane-EtOAc mixture as a solvent, and eluted with a stepwise gradient (40 : 1 to 10 : 1)), to yield compounds 3 (19.4 mg), 4 (5.2 mg), and 9 (5.3 mg), respectively. SL-MC-N (1.4 g) was chromatographed on a reverse-phase column (3.5 × 15 cm, RP C-18, and eluted by a stepwise gradient of H2O-MeOH (40 : 60 to 0 : 100)), to yield compound 8 (42.3 mg).
Collinin (1) − White powder. IR (KBr) cm−1: 2921 (C-H), 1704 (C=O), 1603 (C=C); 1H NMR (CDCl3, 400 MHz): δ 6.24 (1H, d, J = 9.6 Hz, H-3), δ 7.61 (1H, d, J = 9.6 Hz, H-4), δ 7.13 (1H, d, J = 8.8 Hz, H-5), δ 6.86 (1H, d, J = 8.8 Hz, H-6), δ 4.68 (2H, d, J = 6.4 Hz, H-1'), δ 5.48 (1H, t, J = 6.4 Hz, H-2'), δ 2.13~2.04 (4H, m, H-4',5'), 5.07~5.04 (1H, m, H-6'), δ 1.65 (3H, s, H-8'), δ 1.74 (3H, s, H-9'), δ 1.59 (3H, s, H-10'), δ 3.97 (3H, s, H-OCH3); 13C NMR (CDCl3, 100 MHz): δ 160.9 (C-2), δ 113.9 (C-3), δ 143.9 (C-4), δ 113.6 (C-4a), δ 122.9 (C-5), δ 110.4 (C-6), δ 155.2 (C-7), δ 142.0 (C-8), δ 148.4 (C-8a), δ 66.5 (C-1'), δ 119.2 (C-2'), δ 136.9 (C-3'), δ 39.7(C-4'), δ 26.4 (C-5'), δ 123.9 (C-6'), δ 132.1 (C-7'), δ 25.9(C-8'), δ 16.9 (C-9'), δ 17.9 (C-10'), δ 61.6 (C-OCH3); EI-MS m/z: 328 [M]+.
8-Methoxyanisocoumarin (2) − Colorless syrup. IR (KBr) cm−1: 3400 (OH), 2960 (C-H), 1725 (C=O), 1610 (C=C); 1H NMR (CDCl3, 400 MHz): δ 6.25 (1H, d, J = 9.6 Hz, H-3), δ 7.64 (1H, d, J = 9.6 Hz, H-4), δ 7.37 (1H, d, J = 8.4 Hz, H-5), δ 6.86 (1H, dd, J = 8.4, 2.4 Hz, H-6), δ 6.82 (1H, d, J = 2.4 Hz, H-8), δ 4.61 (2H, d, J = 6.4 Hz, H-1'), δ 5.49 (2H, t, J = 6.4 Hz, H-2'), δ 2.79 (2H, d, J = 6.4 Hz, H-4'), δ 5.65 (2H, m, H-5',6'), δ 1.33 (3H, s, H-8'), δ 1.75 (3H, s, H-9'), δ 1.33 (3H, s, H-10'); 13C NMR (CDCl3, 100 MHz): δ 162.3 (C-2), δ 113.2 (C-3), δ 143 (C-4), δ 113.4 (C-4a), δ 128.9 (C-5), δ 112.7 (C-6), δ 161.5 (C-7), δ 101.7 (C-8), δ 156.1 (C-8a), δ 65.6 (C-1'), δ 119.5 (C-2'), δ 141.3 (C-3'), δ 42.3 (C-4'), δ 124.0 (C-5'), δ 140.7 (C-6'), δ 70.9 (C-7'), δ 30.0 (C-8'), δ 17.0 (C-9'), δ 30.0 (C-10'); FAB-MS m/z : 337 [M+ Na]+.
7-(6'R-hydroxy-3',7'-dimethylocta-2',7'-dienyloxy)-coumarin (3) − Colorless crystal. IR (KBr) cm−1: 3329 (OH), 1703 (C=O), 1604 (C=C); 1H NMR (CDCl3, 400 MHz): δ 6.23 (1H, d, J = 9.6 Hz, H-3), δ 7.63 (1H, d, J = 9.6 Hz, H-4), δ 7.36 (1H, d, J = 8.4 Hz, H-5), δ 6.84 (1H, dd, J = 8.4, 2.4 Hz, H-3), δ 6.80 (1H, d, J = 2.4 Hz, H-8), δ 4.59 (2H, d, J = 6.4 Hz, H-1'), δ 5.49 (1H, t, J = 6.4 Hz, H-2'), δ 2.13 (2H, m, H-4'), δ 1.67 (2H, m, H-5'), δ 4.05 (1H, t, J = 6.4 Hz, H-6'), δ 4.94 (1H, s, H-8'a), δ 4.84 (1H, s, H-8'b), δ 1.73 (3H, s, H-9'), δ 1.77 (3H, s, H-10'); 13C NMR (CDCl3, 100 MHz): δ 162.3 (C-2), δ 113.2 (C-3), δ 143.7 (C-4), δ 113.4 (C-4a), δ 128.9 (C-5), δ 112.6 (C-6), δ 161.5 (C-7), δ 101.7 (C-8), δ 156.0 (C-8a), δ 65.6 (C-1'), δ 118.8 (C-2'), δ 142.3 (C-3'), δ 35.6 (C-4'), δ 32.9 (C-5'), δ 75.6 (C-6'), δ 147.5 (C-7'), δ 111.4 (C-8'), δ 17.0 (C-9'), δ 17.7 (C-10'); EI-MS m/z : 314 [M]+.
(E)-4-methly-6-(coumarin-7'-yloxy)hex-4-enal (4) − Colorless crystal. IR (KBr) cm−1: 2922 (C-H), 1727 (C=O), 1610 (C=C); 1H NMR (CDCl3, 400 MHz): δ 6.25 (1H, d, J = 9.6 Hz, H-3), δ 7.64 (1H, d, J = 9.6 Hz, H-4), δ 7.37 (1H, d, J = 8.4 Hz, H-5), δ 6.84 (1H, dd, J = 8.4, 2.4 Hz, H-6), δ 6.80 (1H, d, J = 2.4 Hz, H-8), δ 4.60 (2H, d, J = 6.4 Hz, H-1'), δ 5.49 (1H, t, J = 6.4 Hz, H-2'), δ 2.43 (2H, t, J = 7.2 Hz, H-4'), δ 2.62 (2H, td, J = 7.2, 1.2 Hz, H-5'), δ 9.80 (1H, t, J = 1.2 Hz, H-6'), δ 1.78 (3H, s, H-7'), δ 6.25 (1H, d, J = 9.6 Hz, H-3), δ 7.64 (1H, d, J = 9.6 Hz, H-4), δ 7.37 (1H, d, J = 8.4 Hz, H-5), δ 6.84 (1H, dd, J = 8.4, 2.4 Hz, H-6), δ 6.80 (1H, d, J = 2.4 Hz, H-8); 13C NMR (CDCl3, 100 MHz): δ 65.4 (C-1'), δ 119.6 (C-2'), δ 140.4 (C-3'), δ 31.6 (C-4'), δ 41.9 (C-5'), δ 201.8 (C-6'), δ 17.1 (C-7'), δ 162.1 (C-2), δ 113.2 (C-3), δ 143.7 (C-4), δ 113.3 (C-4a), δ 128.9 (C-5), δ 112.7 (C-6), δ 161.5 (C-7), δ 101.7 (C-8), δ 156.0 (C-8a); EI-MS m/z : 272 [M]+.
Lupeol (5) −White powder. IR (KBr) cm−1: 3300 (OH), 2943 (C-H), 1637 (C=C); 1H NMR (CDCl3, 400 MHz): δ 3.20 (1H, dd, J = 11.0, 3.8 Hz, H-3), δ 2.38 (1H, m, H-19), δ 0.97 (3H, s, H-23), δ 0.77 (3H, s, H-24), δ 0.83 (3H, s, H-25), δ 1.03 (3H, s, H-26), δ 0.95 (3H, s, H-27), δ 0.79 (3H, s, H-28), δ 4.69 (1H, d, J = 2.4 Hz, H-29a), δ 4.57 (1H, d, J = 2.4 Hz, H-29b), δ 1.68 (3H,s, H-30); 13C NMR (CDCl3, 100 MHz): δ 38.9 (C-1), δ 27.7 (C-2), δ 79.2 (C-3), δ 39.2 (C-4), δ 55.5 (C-5), δ 18.5 (C-6), δ 34.5 (C-7), δ 41.0 (C-8), δ 50.6 (C-9), δ 37.4 (C-10), δ 21.1 (C-11), δ 25.3 (C-12), δ 38.3 (C-13), δ 43.0 (C-14), δ 27.7 (C-15), δ 35.8 (C-16), δ 43.2 (C-17), δ 28.2 (C-18), δ 48.5 (C-19), δ 151.1 (C-20), δ 30 (C-21), δ 40.2 (C-22), δ 28.2 (C-23), δ 16.2 (C-24), δ 16.3 (C-25), δ 15.9 (C-26), δ 14.7 (C-27), δ 18.2 (C-28), δ 19.5 (C-29), δ 109.5 (C-30); EI-MS m/z : 426 [M]+.
epi-Lupeol (6) − White powder. IR (KBr) cm−1: 3666 (OH), 2924 (C-H), 1560 (C=C); 1H NMR (CDCl3, 400 MHz): δ 3.38 (1H, m, H-3), δ 2.38 (1H, m, H-19), δ 0.96 (3H, s, H-23), δ 0.84 (3H, s, H-24), δ 0.83 (3H, s, H-25), δ 1.03 (3H, s, H-26), δ 0.93 (3H, s, H-27), δ 0.79 (3H, s, H-28), δ 4.69 (1H, d, J = 2.4 Hz, H-29a), δ 4.56 (1H, d, J = 2.4 Hz, H-29b), δ 1.68 (3H, s, H-30); 13C NMR (CDCl3, 100 MHz): δ 38.9 (C-1), δ 27.7 (C-2), δ 79.2 (C-3), δ 39.2 (C-4), δ 55.5 (C-5), δ 18.5 (C-6), δ 34.5 (C-7), δ 41.0 (C-8), δ 50.6 (C-9), δ 37.4 (C-10), δ 21.1 (C-11), δ 25.3 (C-12), δ 38.3 (C-13), δ 43.0 (C-14), δ 27.7 (C-15), δ 35.8 (C-16), δ 43.2 (C-17), δ 48.2 (C-18), δ 48.5 (C-19), δ 151.1 (C-20), δ 30.1 (C-21), δ 40.2 (C-22), δ 28.1 (C-23), δ 16.2 (C-24), δ 16.4 (C-25), δ 15.9 (C-26), δ 14.7 (C-27), δ 18.2 (C-28), δ 19.5 (C-29), δ 109.4 (C-30); EI-MS m/z : 426 [M]+.
Phytol (7) − Colorless crystal. IR (KBr) cm−1: 3666 (OH), 2987 (C-H), 1653 (C=C); 1H NMR (CDCl3, 400 MHz): δ 4.15 (2H, d, J = 6.8 Hz, H-1), δ 5.41 (2H, t, J = 6.8 Hz, H-2), δ 1.99 (1H, t, J = 8.0 Hz, H-4), δ 0.86 (3H, d, J = 6.4 Hz, H-16), δ 0.85 (3H, d, J = 6.4 Hz, H-17), δ 0.87 (3H, d, J = 6.4 Hz, H-18), δ 0.88 (3H, d, J = 6.4 Hz, H-19), δ 1.67 (3H, s, H-20); 13C NMR (CDCl3, 100 MHz): δ 59.6 (C-1), δ 123.3 (C-2), δ 140.4 (C-3), δ 40.1 (C-4), δ 25.3 (C-5), δ 36.8 (C-6), δ 33.0 (C-7), δ 37.6 (C-8), δ 24.7 (C-9), δ 37.5 (C-10), δ 32.9 (C-11), δ 37.5 (C-12), δ 25.0 (C-13), δ 39.8 (C-14), δ 28.2 (C-15), δ 22.8 (C-16), δ 22.9 (C-17), δ 20.0 (C-18), δ 19.9 (C-19), δ 16.4 (C-20); EI-MS m/z : 296 [M]+.
Hexadec-3-enoic acid (8) −White powder. IR (KBr) cm−1: 2919 (C-H), 1693 (C=O), 1054 (C-O); 1H NMR (CDCl3, 400 MHz): δ 2.94 (2H, d, J = 5.6 Hz, H-2), δ 5.51 (1H, td, J = 12.8, 5.6 Hz, H-3), δ 5.49 (1H, td, J = 12.8, 5.6 Hz, H-4), δ 1.99 (2H, dd, J = 12.8, 5.6 Hz, H-5), δ 1.33~1.19 (20H, m, H-6~15), δ 0.86 (3H, t, J = 6.4 Hz, H-16); 13C NMR (CDCl3, 100 MHz): δ 175.0 (C-1), δ 37.7 (C-2), δ 134.2 (C-3), δ 122.3 (C-4), δ 32.4 (C-5), δ 31.9 (C-6), δ 29.6~29.5 (C-7~14), δ 22.6 (C-15), δ 13.3 (C-16); EI-MS m/z : 264 [M]+.
Palmitic acid (9) − White powder. IR (KBr) cm−1: 2935 (C-H), 1699 (C=O), 1054 (C-O); 1H NMR (CDCl3, 400 MHz): δ 2.36 (2H, t, J = 6.86 Hz, H-2), δ 1.63 (2H, m, H-3), δ 1.31~1.26 (24H, m, H-4~15), δ 0.89 (3H, t, J = 6.4 Hz, H-16); 13C NMR (CDCl3, 100 MHz): δ 179.9 (C-1), δ 34.2 (C-2), δ 24.9 (C-3), δ 29.9~29.3 (C-4~13), δ 32.1 (C-14), δ 22.9 (C-15), δ 14.3 (C-16); EI-MS m/z : 256 [M]+.
MTT Assay − The cytotoxic activity of each compound on Jurkat T cells was analyzed by 3-(4,5-dimethylthiazole-2-yl)-2,5-biphenyl tetrazolium bromide (MTT) assay (Park et al., 2000). The Jurkat T cells (2.5 × 104 cells/well) were seeded on a 96-well microplate, and were precultured for 36 h. 50 μL of the MTT solution (1.1 mg/mL) was added to each well, and incubated for an additional 4 h. The colored formazan crystal produced from the MTT was dissolved in dimethyl sulfoxide (DMSO). A plate reader was used to measure the optical density (OD) values of the solutions at 540 nm.
Results and Discussion
The nine compounds (1 − 9) (Fig. 1) were isolated from the methylene chloride fraction of the leaves of Z. schinifolium, by repetitive column chromatography, using silica gel and RP-C18. Compound 1 was obtained as white powder with a molecular weight of m/z 328 [M]+, based on EI-MS data. Compound 1 exhibited UV absorption bands at 202 and 323 nm. The IR spectrum of 1 showed absorption bands at 1701 cm−1 (C=O), 2921 (CH) and 1603 (C=C). The 1H NMR spectrum of 1 showed the presence of a 7,8-disubstituted coumarin from the characteristic doublets of H-3 (δH 6.24, J = 9.6 Hz) and H-4 (δH 7.61, J = 9.6 Hz), H-5 (δH 7.13, 1H, d, J = 8.8 Hz) and H-6 (δH 6.86, 1H, d, J = 8.8 Hz). The terpenyl side-chain exhibited signals due to two olefinic protons at δH 5.48 (1H, t, J = 6.4 Hz, H-2') and 5.05 (1H, m, H-6'), three methylenic protons at δH 2.13~2.04 (4H, m, H-4',5') and δH 4.68 (2H, d, J = 6.4 Hz, H2-1'), and three vinylic methyl protons at δH 1.65 (3H, s, H-8'), δH 1.74 (3H, s, H-9'), δH 1.59 (3H, s, H-10'). The 13C NMR spectrum of 1 displayed all the 20 carbons including nine carbons of the coumarin skeletons at δH 160.9 (C-2), 113.9 (C-3), 143.9 (C-4), 113.6 (C-4a), 122.9 (C-5), 110.4 (C-6), 155.2 (C-7) and 142.0 (C-8), 148.4 (C-8a), seven carbons of the terpenyl moiety [δ 66.5 (C-1'), 119.2 (C-2'), 136.9 (C-3'), 39.7 (C-4'), 26.4 (C-5'), 123.9 (C-6'), 132.1 (C-7'), 25.9 (C-8'), 16.9 (C-9'), 17.9 (C-10')] and an additional methoxy unit at δC 61.6 (C-OCH3) and δH 3.97 (3H, s, H-OCH3). Compound 1 was finally identified as collinin by comparison of the physical and spectroscopic data with those in the literature.9
Fig. 1.Chemical structures of compounds 1 − 9 isolated from the leaves of Z. schinifolium.
Compound 2 was isolated as colorless syrup, its IR spectrum displayed absorption bands at 3400 cm−1 (OH), 2960 (C-H), 1725 (C=O), 1610 (C=C). The molecular weight of compound 2 was obtained from FAB-MS with m/z 337 [M + Na]+. The 1H and 13C NMR spectra of compound 2 were identical with those of compound 1 except only for the signal assignable for C-5' [δH 5.65 (1H, m) and δC 70.9] and H-4' [δH 2.79 (2H, d, J = 6.4 Hz, H-4') and δC 42.3], respectively. Compound 2 was therefore elucidated as 8-methoxyanisocoumarin, it was isolated from this plant previously by Tsai et al.10 Compound 3 was obtained as colorless crystal. The IR (KBr) displayed absorption bands at 3329 cm−1 (OH), 1703 (C=O), 1604 (C=C). The 1H and 13C NMR spectra of 3 showed the presence of a 7-substituted coumarin from the characteristic doublets of H-3 (δH 6.23, 1H, d, J = 9.6 Hz) and H-4 (δH 7.61, 1H, d, J = 9.6 Hz), a pair of ortho-coupled protons of H-5 (δH 7.36, 1H, d, J = 8.4 Hz) and H-6 (δH 6.86, 1H, d, J = 8.8 Hz) which was meta-coupled with H-8 (δH 6.80, 1H, d, J = 2.4 Hz). The terpenyl side-chain exhibited signals due to one olefinic proton at δH 5.49 (1H, t, J = 6.4 Hz, H-2'), three methylenic protons at δH 4.59 (2H, d, J = 6.4 Hz, H-1'), δH 2.13 (2H, m, H-4'), δH 1.67 (2H, m, H-5'), and two vinylic methyl protons at δH 1.73 (3H, s, H-9'), δH 1.77 (3H, s, H-10'). In addition, the 1H and 13C NMR spectra of 3 possessed an oxygenated olefinic proton at δH 4.05 (1H, t, J = 6.4 Hz, H-6') and δC 75.6 (C-6') due to the attachment of a hydroxyl group at C-6, an germinal methylene protons at δH 4.94 (1H, s, H-8'a), δH 4.84 (1H, s, H-8'b) with corresponding carbons at δC 147.5 (C-7') and 111.4 (C-8') were further supported for this observation. Detailed comparison of the 1H and 13C NMR spectra of compound 3 with those published in the literature,11 led to the structural identification of compound 3 to be 7-(6'R-hydroxy-3',7'-dimethylocta-2',7'-dienyloxy)-coumarin.
The 1H and 13C NMR spectra of compound 4 revealed an identical structure with compound 4, except for the disappearances of the oxygenated olefinic proton at δH 4.05 (1H, t, J = 6.4 Hz, H-6'), the germinal methylene protons at δH 4.94 (1H, s, H-8'a), δH 4.84 (1H, s, H-8'b) and the vinylic methyl protons at δH 1.77 (3H, s, H-10'). Instead of that an aldehyde group was observed in compound 4 at δH 9.80 (1H, t, J = 1.2 Hz, H-6') and the corresponding carbon at δC 201.8 (C-6'). Compound 4 was thus identified as (E)-4-methly-6-(coumarin-7'-yloxy)hex-4-enal.12 Compounds 5 and 6 were isolated and identified to be lupeol13 and epi-lupeol,14 respectively by comparing the physicochemical and spectroscopic data with the published literatures. Three fatty acid derivatives were also characterized as phytol (7),15 (8) hexadec-3-enoic acid,16 and (9) palmitic acid,17 respectively. To the best of our knowledge, compounds 4, 6 and 8 were isolated from this plant for the first time.
The nine compounds isolated from Z. schinifolium were tested for their cytotoxic activity against the Jurkat T cells,18 and the result are presented in Table 1. Among those, compounds 1 and 7 showed potential growth inhibition effects with IC50 values of 45.58 and 47.51 μM, respectively. While, auraptene, used as the positive control, possessed weaker activity with IC50 value of 55.36 μM. Compounds 3, 4 and 9 showed moderate activity with IC50 values ranging around 80.58 to 85.83 μM. The other compounds 8 and 9 were weak (IC50 value 96.87 μM) or no active (IC50 > 100 μM), respectively. The cytotoxicities of compounds 5 and 6 were not able to investigate due to their insolubility in DMSO.
Table 1.aThe inhibitory effects are represented as the molar concentration (μM) giving 50% inhibition (IC50) relative to the vehicle control. These data represent the average values of three repeated experiments. bThe compound used as positive control. cThe compounds were not tested.
Compound 1, collinin, was previously found to be an inhibitor of hepatitis B virus (HBV) DNA replication in a HBV-transfected cell line.19 Koheno et al. had suggested that certain phenyloxycoumarins, such as auraptene and collinin, could serve as an effective agent against colitisrelated colon cancer development in rodents.20 Costa et al. reported an anticonvulsant effect of phytol in a pilocarpine model in mice.21 In this study, we found that collinin (1) and phytol (7) possessed potential cytotoxicity against Jurkat T cells, suggesting that Z. schinifolium and its active principles may be useful for the development of agent in combat with cancer.
참고문헌
- Paik, S.Y.; Koh, K. H.; Baek, S. M.; Paek, S. H.; Kim, J. A. Biol. Pharm. Bull. 2005, 28, 802-807. https://doi.org/10.1248/bpb.28.802
- Kim, D. S.; Ahn, B. W.; Yeum, D. M.; Lee, D. H.; Kim, S. B.; Park, Y. H. Bull. Korean Fish. Soc. 1987, 20, 463-468.
- Liu, Z. L.; Chu, S. S.; Jiang, G. H. J. Agric. Food Chem. 2009, 57, 10130-10133. https://doi.org/10.1021/jf9012983
- Han, M. K.; Kim, S. I.; Ahn, Y. J. J. Stored Prod. Res. 2006, 42, 15-22. https://doi.org/10.1016/j.jspr.2004.11.002
- Liu, S. L.; Wei, L. X.; Wang, D.; Gao, C. Y. Yao Xue Xue Bao 1991, 26, 836-840.
- Mun, S. I.; Ryu, H. S.; Lee, H. J. Choi, J. S. Korean J. Food Nutr. 1994, 23, 466-471.
- Jo, Y. S.; Huong, D. T.; Bae, K.; Lee, M. K.; Kim, Y. H. Planta Med. 2002, 68, 84-85. https://doi.org/10.1055/s-2002-20056
- Yang, X. J Agric Food Chem. 2008, 56, 1689-1696. https://doi.org/10.1021/jf0728101
- Chen, I. S.; Lin, Y. C.; Tsai, I. L.; Teng, C. M.; Ko, F. N.; Ishikawa, T.; Ishii, H. Phytochemistry, 1995, 39, 1091-1097. https://doi.org/10.1016/0031-9422(95)00054-B
- Tsai, I. L.; Lin, W. Y.; Teng, C. M.; Ishikawa, T.; Doong, S. L.; Huang, M. W.; Chen, Y. C.; Chen, I. S. Planta Med. 2000, 66, 618-623. https://doi.org/10.1055/s-2000-8648
- Jeong, S. H.; Han, X. H.; Hong, S. S.; Hwang, J. S.; Hwang, J. H.; Lee, D.; Lee. M. K.; Ro, J. S.; Hwang, B. Y. Arch. Pharm. Res. 2006, 29, 1119-1124. https://doi.org/10.1007/BF02969302
- Nakatani, N.; Yamada, Y.; Fuwa, H. Agric. Biol. Chem. 1987, 51, 419-423. https://doi.org/10.1271/bbb1961.51.419
- Fuchino, H.; Satoh, T.; Tanaka, N. Chem. Pharm. Bull. 1995, 43, 1937-1942. https://doi.org/10.1248/cpb.43.1937
- Souza, A. D. L.; Da Rocha, A. F. I.; Pinheiro, M. L. B.; Andrade, C. H. S.; Galota, A. L. Q.; Dos Santos, M. P. Quim. Nova. 2011, 24, 439-442.
- Aoki, T.; Takagi, K.; Hirata, T.; Suga, T. Phytochemistry 1982, 21, 1361-1363. https://doi.org/10.1016/0031-9422(82)80142-8
- Zhao, N.; Gao, H. Y.; Sun, B. H.; Wu, L. J. J. Shenyang Pharm. Univ. 2007, 24, 211-214.
- Crane, S.; Aurore, G.; Joseph, H.; Mouloungui, Z.; Bourgeois, P. Phytochemistry 2005, 66, 1825-1831. https://doi.org/10.1016/j.phytochem.2005.06.009
- Park, E. J.; Nan, J. X.; Kim, J. Y.; Kang, H. C.; Choi, J. H.; Lee, S. J.; Lee, B. H.; Kim, S. J.; Lee, J. H.; Kim, Y. C.; Sohn, D. H. J. Pharm. Pharmacol. 2000, 52, 875-881. https://doi.org/10.1211/0022357001774561
- Chang, C. T.; Doong, S. L.; Tsai, I. L.; Chen, I. S. Phytochemistry 1997, 45, 1419-1422. https://doi.org/10.1016/S0031-9422(97)89023-1
- Kohno, H.; Suzuki, R.; Curini, M.; Epifano, F.; Maltese, F.; Gonzales, S. P.; Tanaka, T. Int. J. Cancer 2006, 118, 2936-2942. https://doi.org/10.1002/ijc.21719
- Costa, J. P.; Ferreira, P. B.; De Sousa, D. P.; Jordan, J.; Freitas, R. M., Neurosci. Lett. 2012, 523, 115-118. https://doi.org/10.1016/j.neulet.2012.06.055